Table 2.
General information of the enrolled patients.
| Variable | Intervention group (n = 66) | Control group (n = 66) | t/x 2 | p |
|---|---|---|---|---|
| Age (y) | 60.5 ± 16.9 | 60.3 ± 18.7 | 0.044 | 0.965 |
| Male | 37 (56.1) | 47 (71.2) | 3.274 | 0.070 |
| Body mass index | 22.5 ± 3.0 | 21.7 ± 2.4 | 1.662 | 0.099 |
| Diagnosis category | 1.423 | 0.759 | ||
| Medical | 48 (72.7) | 52 (78.8) | ||
| Surgical | 12 (18.2) | 11 (16.7) | ||
| Obstetric and gynaecologic | 3 (4.5) | 1 (1.5) | ||
| Others | 3 (4.5) | 2 (3.0) | ||
| APACHE II score | 22.4 ± 6.8 | 21.7 ± 6.8 | 0.603 | 0.548 |
| Sepsis | 20 (30.3) | 13 (19.7) | 1.980 | 0.159 |
| Coronary heart disease | 10 (15.2) | 7 (10.6) | 0.608 | 0.436 |
| Hypertension | 18 (27.3) | 18 (27.3) | 0.000 | 1.000 |
| Type 2 diabetes | 24 (36.4) | 12 (18.2) | 5.500 | 0.019 |
| Liver disease | 7 (10.6) | 4 (6.1) | 0.893 | 0.345 |
| PAOD | 6 (9.1) | 7 (10.6) | 0.085 | 0.770 |
| Artificial airway type | 0.075 | 0.784 | ||
| Tracheal intubation | 59 (89.4) | 58 (87.9) | ||
| Tracheotomy tube | 7 (10.6) | 8 (12.1) | ||
| Vasoactive drugs | 45 (68.2) | 38 (57.6) | 1.590 | 0.207 |
| MRC-SS | 34.3 ± 11.4 | 31.5 ± 10.4 | 1.453 | 0.149 |
| Capacity of mobility | ||||
| ICU mobility scale | 1.1 ± 1.0 | 1.0 ± 1.0 | 0.171 | 0.864 |
| Perme score | 7.0 ± 4.1 | 6.2 ± 3.7 | 1.263 | 0.209 |
APACHE II, acute physiology and chronic health evaluation II; MRC-SS, Medical Research Council sum score; PAOD, peripheral arterial occlusive disease. Data described in mean ± SD, absolute number (%).